← Browse by Condition
Medical Condition

carney stratakis dyad

Total Trials
1
Recruiting Now
1
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for carney stratakis dyad sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — carney stratakis dyad Clinical Trials

How many clinical trials are currently recruiting for carney stratakis dyad?
ClinicalMetric currently tracks 1 actively recruiting clinical trials for carney stratakis dyad, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 1. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for carney stratakis dyad?
carney stratakis dyad research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a carney stratakis dyad clinical trial?
Eligibility criteria for carney stratakis dyad trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Universidad Nacional Autonoma de Mexico 1 trial

Recruiting Clinical Trials

NCT06523582
Recruiting
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Enrollment
750 pts
Location
Mexico
Sponsor
Universidad Nacional Autonoma ...
View Trial →

Related Conditions

neuroendocrine neoplasm (1) neuroendocrine neoplasm of gastrointestinal tract (1) neuroendocrine neoplasm of lung (1) thymic neuroendocrine neoplasm (1) neuroendocrine tumor of pancreas (1) gastrointestinal stromal tumors (1) medullary thyroid cancer (1) paraganglioma (1) pheochromocytoma (1) primary hyperparathyroidism (1) pituitary tumor (1) multiple endocrine neoplasia type 1 (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology